Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Martina Bebin

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Annals of Neurology|December 11, 2023
Reply to "Chance Bias Arising from TSC2 Mutation Imbalance in the PREVeNT Trial"E Martina Bebin
Epilepsia|March 6, 2020
Response: Letter to the Editor - Scalp EEG spikes predict impending epilepsy in TSC infants: A longitudinal observational studyJoyce Wu, E Martina Bebin
Epilepsy & Behavior : E&B|October 6, 2014
Cannabis, cannabidiol, and epilepsy--from receptors to clinical responseJerzy P Szaflarski, E Martina Bebin
Pediatrics in Review|March 3, 2017
Neurocutaneous Disorders in ChildrenBruce R Korf, E Martina Bebin
Pediatric Neurology|August 11, 2004
Chorea as manifestation of epilepsia partialis continua in a childPongkiat Kankirawatana, Leon S Dure, E Martina Bebin
Epilepsy & Behavior : E&B|June 11, 2018
Affiliate stigma and caregiver burden in intractable epilepsyBarbara Hansen, Magdalena Szaflarski, E Martina Bebin, et al.
Epilepsy & Behavior : E&B|February 26, 2017
Social correlates of health status, quality of life, and mood states in patients treated with cannabidiol for epilepsyMagdalena Szaflarski, Barbara Hansen, E Martina Bebin, et al.
Annals of Neurology|November 13, 2023
Commentary Regarding the Results of the PREVeNT and EPISTOP TrialsSergiusz Jóźwiak, Katarzyna Kotulska, E Martina Bebin, et al.
Neurocase|October 25, 2017
The use of cannabidiol for seizure management in patients with brain tumor-related epilepsyPaula Province Warren, E Martina Bebin, L Burt Nabors, et al.
Epilepsy & Behavior : E&B|April 20, 2019
Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsyTyler E Gaston, Magdalena Szaflarski, Barbara Hansen, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Annals of Neurology|December 11, 2023
Reply to "Chance Bias Arising from TSC2 Mutation Imbalance in the PREVeNT Trial"E Martina Bebin
Epilepsia|March 6, 2020
Response: Letter to the Editor - Scalp EEG spikes predict impending epilepsy in TSC infants: A longitudinal observational studyJoyce Wu, E Martina Bebin
Epilepsy & Behavior : E&B|October 6, 2014
Cannabis, cannabidiol, and epilepsy--from receptors to clinical responseJerzy P Szaflarski, E Martina Bebin
Pediatrics in Review|March 3, 2017
Neurocutaneous Disorders in ChildrenBruce R Korf, E Martina Bebin
Pediatric Neurology|August 11, 2004
Chorea as manifestation of epilepsia partialis continua in a childPongkiat Kankirawatana, Leon S Dure, E Martina Bebin
Epilepsy & Behavior : E&B|June 11, 2018
Affiliate stigma and caregiver burden in intractable epilepsyBarbara Hansen, Magdalena Szaflarski, E Martina Bebin, et al.
Epilepsy & Behavior : E&B|February 26, 2017
Social correlates of health status, quality of life, and mood states in patients treated with cannabidiol for epilepsyMagdalena Szaflarski, Barbara Hansen, E Martina Bebin, et al.
Annals of Neurology|November 13, 2023
Commentary Regarding the Results of the PREVeNT and EPISTOP TrialsSergiusz Jóźwiak, Katarzyna Kotulska, E Martina Bebin, et al.
Neurocase|October 25, 2017
The use of cannabidiol for seizure management in patients with brain tumor-related epilepsyPaula Province Warren, E Martina Bebin, L Burt Nabors, et al.
Epilepsy & Behavior : E&B|April 20, 2019
Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsyTyler E Gaston, Magdalena Szaflarski, Barbara Hansen, et al.
Pageof 9